Family Medicine · Miami, FL
NPI
1982783353
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
962 SW 82nd Ave
Miami, FL, 33144
Phone (786) 619-3360
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$868K
12,777 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Maurin Jimenez prescribed most often to Medicare patients was Vitamin D2 (Ergocalciferol (Vitamin D2)), with 633 prescriptions and refills. In total Maurin Jimenez wrote 12,777 Medicare prescriptions that cost $868K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Vitamin D2 Ergocalciferol (Vitamin D2) | 633 | 637 | 112 | $2,721 |
| Folic Acid Generic | 599 | 606 | 67 | $1,041 |
| Rosuvastatin Calcium Generic | 530 | 1,567 | 167 | $3,902 |
| Atorvastatin Calcium Generic | 453 | 1,321 | 147 | $3,322 |
| Gabapentin Generic | 419 | 799 | 117 | $4,775 |
| Losartan Potassium Generic | 362 | 1,047 | 111 | $891 |
| Amlodipine Besylate Generic | 349 | 936 | 96 | $310 |
| Metformin Hcl Generic | 324 | 937 | 102 | $439 |
| Pantoprazole Sodium Generic | 274 | 702 | 81 | $5,090 |
| Levothyroxine Sodium Generic | 268 | 673 | 71 | $3,617 |
| Tradjenta Linagliptin | 254 | 254 | 35 | $127K |
| Lisinopril Generic | 247 | 678 | 79 | $416 |
| Hydrochlorothiazide Generic | 243 | 682 | 73 | $362 |
| Metoprolol Succinate Generic | 241 | 706 | 75 | $5,072 |
| Famotidine Generic | 234 | 518 | 71 | $1,534 |
Brand drugs: 1,588 claims; generic drugs: 10,952 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Maurin Jimenez were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.